Methylation Screening of the TGFBI Promoter in Lung and Prostate Cancer
Author Information
Author(s): Shah Jinesh N, Shao Genze, Hei Tom K, Zhao Yongliang
Primary Institution: Columbia University
Hypothesis
The study investigates the methylation status of the TGFBI promoter in human lung and prostate cancer specimens.
Conclusion
The study found that dense methylation of the TGFBI promoter is associated with invasiveness in prostate cancer and metastasis in lung cancer.
Supporting Evidence
- 44.0% of lung cancer samples showed methylated CpG sites in the TGFBI promoter.
- 82.0% of prostate cancer samples harbored methylated CpG sites in the TGFBI promoter.
- Dense methylation of the TGFBI promoter was associated with a metastatic phenotype in lung cancer.
- Dense methylation of the TGFBI promoter was associated with locoregional invasiveness in prostate cancer.
Takeaway
The researchers looked at how a specific gene's control region is changed in lung and prostate cancers, finding that changes in this region can help predict how aggressive the cancer is.
Methodology
The study used methylation-specific PCR to analyze the TGFBI promoter in lung and prostate cancer samples.
Limitations
The exact percent tumor involvement in the slices of prostate tissue used for DNA extraction was not quantified.
Participant Demographics
The study included 50 lung cancer patients and 50 prostate cancer patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website